Judith Salmon Kaur | |
---|---|
Born | 1945 (age 78–79) |
Alma mater | University of North Dakota University of Colorado Boulder |
Scientific career | |
Institutions | Mayo Clinic |
Judith Salmon Kaur (born 1945) is an American oncologist who is Director of the Native American Programs in the Mayo Clinic Cancer Center. According to Indian Country Today , Kaur is one of only two Native American oncologists working in the United States.
Kaur is of Choctaw–Cherokee heritage. [1] At the age of five, her grandmother told her that she was "meant to be a healer,". [2] She was the first member of her family to graduate from high school, and, after graduating from Augustana College, started her professional career as a teacher. [2] Whilst working as a teacher, Kaur had a daughter and got married. Her husband would come home to see her spending her evenings reading Scientific American . [3] Her husband eventually challenged her to apply to medical school, and in 1975 she was accepted to the University of North Dakota Indian Health Service's Indians into Medicine Program (INMED) programme, which supports Native Americans and Alaska Natives in pursuing careers in healthcare. [4] She originally intended to earn her medical degree and move back to the reservation to work in family medicine. [5] In her third year of medical school, Kaur decided to specialise as an oncologist. [4] She eventually completed her medical degree at the University of Colorado School of Medicine. [5]
Kaur is committed to ending health inequities for indigenous communities, looking to transform the medical outcomes of people suffering from cancer. [4] She has focused on increasing participation in clinical trials and supporting indigenous students in pursuing careers in medicine. [4] As one of the first National Cancer Institute (NCI) investigators to collect data on cancer prevalence and perceptions amongst indigenous communities, she has raised awareness of cancer amongst tribes in the Midwest United States. Before the work of Kaur, there was a misconception that cancer was a 'white people's disease'. [2]
In particular, Kaur specialises on women's cancers, with a focus on breast and cervical cancer. [6] She has studied the biomarkers of breast cancer in Alaska Natives and Native Americans. [6] She also worked with Alaska Native pregnant women on smoking cessation and exposure to carcinogens. [2] Since founding the resource centre in 1999, Kaur has served as medical director of the American Indian/Alaska Native Cancer Information Resource Center and Learning Exchange (Native CIRCLE). [7] [8] Alongside Native CIRCLE, Kaur leads the American Indian / Alaska Native Initiative on Cancer, Spirit of EAGLES. [9] [10] The programme looks to provide culturally relevant education and research. [11] In particular, Kaur works to improve the access of indigenous communities to the Affordable Care Act. [3]
In 2007 Kaur published the Annual Report to the Nation on the Status of Cancer, which identified that despite the progress the United States had made in reducing the prevalence of cancer, this was not reflected in indigenous populations. [12] Kaur was named the 2017 Richard Swanson Humanitarian Award winner by her alma mater Augustana College. [13] In 2018 she was awarded the Mayo Clinic Distinguished Alumni Award [14] for her work with Native American communities. [15] [16]
Mayo Clinic is a nonprofit American academic medical center focused on integrated health care, education, and research. It employs over 7,300 physicians and scientists, along with another 66,000 administrative and allied health staff, across three major campuses: Rochester, Minnesota; Jacksonville, Florida; and Phoenix/Scottsdale, Arizona. The practice specializes in treating difficult cases through tertiary care and destination medicine. It is home to the top-15 ranked Mayo Clinic Alix School of Medicine in addition to many of the highest regarded residency education programs in the United States. It spends over $660 million a year on research and has more than 3,000 full-time research personnel.
Alternative cancer treatment describes any cancer treatment or practice that is not part of the conventional standard of cancer care. These include special diets and exercises, chemicals, herbs, devices, and manual procedures. Most alternative cancer treatments do not have high-quality evidence supporting their use and many have been described as fundamentally pseudoscientific. Concerns have been raised about the safety of some purported treatments and some have been found unsafe in clinical trials. Despite this, many untested and disproven treatments are used around the world.
Harry F. Bisel, M.D. (1918–1994) was an American oncologist. With Fred Ansfield, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane Wright, was one of the founding members of the American Society of Clinical Oncology (ASCO). This group of pioneering doctors, through the formation of ASCO, is largely credited with the development of modern American clinical oncology. In 1964, Bisel was elected the first president of ASCO. He was active in the American Cancer Society and was a consultant to the National Cancer Institute. Bisel was a founding member of the American Society of Preventive Oncology as well as the American Association for Cancer Education.
Oncology is a branch of medicine that deals with the study, treatment, diagnosis, and prevention of cancer. A medical professional who practices oncology is an oncologist. The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass". Oncology is concerned with:
Ketayun Ardeshir Dinshaw FRCR was a prominent personality in the field of Indian medicine and played a significant role in the evolution of modern cancer care in India, and the development of effective radiation therapy. In 2001, the President of India conferred on her the Padma Shri. A prominent news channel has described her as: “The ultimate hope and the last possible post to cling onto for the cancer-struck in India”. Over a thirty-year period, Dinshaw revolutionised cancer medicine in India, refining multi-modal treatments as the exception rather than the rule.
Yvette Roubideaux is an American doctor and public health administrator. She is a member of the Rosebud Sioux Tribe of South Dakota.
George Bosl is an American cancer researcher, holder of the Patrick M. Byrne Chair in Clinical Oncology at the Memorial Sloan-Kettering Cancer Center in New York City, and is a professor of medicine at the Weill Cornell Medical College. In 1997, he was appointed chair of the Department of Medicine at Sloan-Kettering, a position which he held until 2015. In 2019, he was named Memorial Sloan Kettering's first ombudsperson.
Christopher G. Chute is a Bloomberg Distinguished Professor at Johns Hopkins University, physician-scientist and biomedical informatician known for biomedical terminologies and health information technology (IT) standards. He chairs the World Health Organization Revision Steering Group for the revision of the International Classification of Diseases (ICD-11).
Edith A. Pérez is a Puerto Rican hematologist-oncologist. She is the Serene M. and Frances C. Durling Professor of Medicine at the Mayo Clinic Alix School of Medicine.
Nadine Rena Caron FACS, FRCSC,, is a Canadian surgeon. She is the first Canadian female general surgeon of First Nations descent (Ojibway), as well as the first female First Nations student to graduate from University of British Columbia's medical school.
The Mayo Clinic Alix School of Medicine (MCASOM), formerly known as Mayo Medical School (MMS), is a research-oriented medical school based in Rochester, Minnesota, with additional campuses in Arizona and Florida. MCASOM is a school within the Mayo Clinic College of Medicine and Science (MCCMS), the education division of the Mayo Clinic. It grants the Doctor of Medicine (M.D.) degree, accredited by the Higher Learning Commission (HLC) and the Liaison Committee on Medical Education (LCME). In November 2018, the school was renamed in honor of a $200 million donation from businessman Jay Alix.
Michelle Leigh Monje-Deisseroth is a neuroscientist and neuro-oncologist. She is a professor of neurology at Stanford University and an investigator with the Howard Hughes Medical Institute. She develops new treatments for diffuse intrinsic pontine glioma.
Robin Patel is a Canadian born microbiologist and Elizabeth P. and Robert E. Allen Professor of Individualized Medicine, a Professor of Microbiology, and a Professor of Medicine at the Mayo Clinic. She is widely recognized as a leader in the field of clinical microbiology and has held a variety of leadership positions including 2019–2020 President of the American Society for Microbiology (ASM) and Director of the Antibacterial Resistance Leadership Group (ARLG) Laboratory Center of the National institutes of Health. She is currently the Vice Chair of Education in the Department of Laboratory Medicine and Pathology at the Mayo Clinic, and Director of the Mayo Clinic's Infectious Diseases Research Laboratory, where she studies biofilms, antimicrobial resistance, periprosthetic joint infection and diagnostic testing of bacteria.
Lucile L. Adams-Campbell is the first African-American woman to receive a PhD in epidemiology in the United States. She serves as the Professor of Oncology at Lombardi Comprehensive Cancer Center and associate director for Minority Health at the Georgetown University Medical Center. She is a Fellow of the National Academy of Medicine, and the Washington DC Hall of Fame.
Jennie R. Joe is an American academic, medical anthropologist, and fellow of the Society for Applied Anthropology. Initially trained as a nurse, she was one of the health clinic workers during Occupation of Alcatraz in 1969. She is a professor in the Departments of Family and Community Medicine and American Indian Studies at the University of Arizona. Joe was one of the inaugural board members for the Smithsonian's National Museum of the American Indian and serves on the board of the Urban Indian Health Commission.
Patricia Anne Ganz is an American medical oncologist. She is a professor of health policy and management in the Fielding School of Public Health and a professor of medicine in the David Geffen School of Medicine at UCLA. In 2007, she was elected to the Institute of Medicine.
Worta J. McCaskill-Stevens was an American physician-scientist and medical oncologist specialized in cancer disparities research, management of comorbidities within clinical trials, and molecular research for cancer prevention interventions. She was chief of the community oncology and prevention trials research group at the National Cancer Institute.
Dedra S. Buchwald is an American epidemiologist. She is a full professor at the Washington State University and director of their Initiative for Research and Education to Advance Community Health.
Cheryl Lynn Willman is an American cancer researcher and executive director of Mayo Clinic Cancer Programs at the Mayo Clinic Comprehensive Cancer Center.
Edward T. Creagan is an American retired oncologist, author, educator, and advocate for animal-assisted therapy. Creagan is based in Rochester, Minnesota, where he has been affiliated with the Mayo Clinic for over forty years. He taught medical oncology at the Mayo Clinic College of Medicine and is professor emeritus of oncology and palliative and hospice medicine at the Mayo Clinic Medical School. Creagan was the first Mayo Clinic consultant to become board certified in hospice and palliative medicine.